ACETO Corp (ACET) Adds New Board Member

September 6, 2016 3:53 PM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

ACETO Corporation (Nasdaq: ACET) announced that it has appointed William C. Kennally, III, 61 years old, to its Board of Directors, effective September 6, 2016.

Chairman of the Board, Albert Eilender, commented, “We are pleased to welcome Bill to the ACETO board. He has deep, multi-faceted experience in pharmaceutical sales, general management, and business leadership gained over a 37-year distinguished career. We look forward to drawing on Bill’s vast experience and industry knowledge in the pharmaceutical arena.”

Mr. Kennally started his career in pharmaceutical sales in 1979 with The Upjohn Company which was later acquired by Pharmacia. During his career, Bill held positions of increasing responsibility within Pfizer and Pharmacia including President, Greenstone, LLC, a generic and authorized generic pharmaceuticals supplier which became a wholly-owned subsidiary of Pfizer, Inc. after Pfizer’s acquisition of Pharmacia. In 2010, Bill became Regional President North America, Global Established Products for Pfizer, and prior to his retirement in 2015 was Regional President North America Advisor, Global Established Pharma with Pfizer.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Management Changes, Management Comments

Related Entities

Definitive Agreement

Add Your Comment